Hospira Healthcare Corporation et al. v The Kennedy Institute of Rheumatology

Call to arrange a consultation

2019

A-395-19; A-396-19; A-397-19

Pending

Biosimilars

Interlocutory appeal in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)

Counsel to:

Hospira Healthcare Corporation

The decision is reported

Partner

Associate